ArticleJournal of scleroderma and related disorders2022

Use of vonoprazan, a novel potassium-competitive acid blocker, for the treatment of proton pump inhibitor-refractory reflux esophagitis in patients with systemic sclerosis.

Yuichiro Shirai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.